+7 (343) 270-75-00

          info@uphc.ru

News

The 3d Scientific and Practical Conference The Ural Peaks. Respiratory Infections 2025 was held in Ekaterinburg on October 15–16 as part of the 4th International Forum Days of Virology 2025. The event organized by the Ministry of Health of the Sverdlovsk Region, the Smorodintsev Research Institute of Influenza, and the Ural State Medical University brought together over 1,100 participants in person and online from 36 cities across Russia.

In September 2025, the Russian Ministry of Health issued a registration certificate for a new dosage form of the broad-spectrum antiviral drug TRIAZAVIRIN® for the treatment of ARVI in school-age children—100 mg.

On October 10, 2025, a representative delegation visited the Medsintez Plant. Among the visitors, there were members of the State Duma of the Russian Federation, representatives of the Government and Legislative Assembly of the Sverdlovsk Region, the head of the Novouralsk Urban District, and leading regional experts in the field of medical science. The main purpose of the visit was to assess the enterprise's success in import-substituting drug production, become familiar with its brand-new products, and discuss development options of the pharmaceutical industry in the region.

Current data on modern approaches to the therapy of acute respiratory viral infections (ARVI) in children were presented at the VI Congress of Children's Physicians of the Moscow Region with international participation «Pediatrics as an Art» (September 3–5, 2025). Zhdanov K. V., Doctor of Medical Sciences, Professor, Director of the Scientific and Clinical Center of the Federal State Budgetary Institution «Federal Scientific and Clinical Center of Infectious Diseases of the Federal Medical and Biological Agency of Russia», corresponding member of the Russian Academy of Sciences, and honored scientist of the Russian Federation, delivered a key report titled «Current Issues of the ARVI Therapy in Children. New Data.»

MedicorPharma-Ural LLC

 

MedicorPharma-Ural LLC has been a supplier of equipment for nuclear medicine and radioisotope products to healthcare institutions throughout Russia and abroad for more than 10 years.

Products supplied:

- radiopharmaceuticals based on I-131, Sm-153, Sr-89;
— technetium Тс-99m generators;
— microsources of radioactive emission based on I-125;
— intraoperative gamma-probe RadPointer;
— kits for the preparation of radiopharmaceuticals labeled with 99mTc;
— other products for nuclear medicine.

MedicorPharma-Ural LLC provides services for:

— support in customs clearance of radioisotope medical products for export and import operations;
— transportation of radioactive cargo (hazard class 7);
— development of projects for bringing goods and services to the Russian market;
— registration of the shipping packaging set;
— training in the use of medical devices and radiopharmaceuticals; – and others.

The company is a manufacturer of the RadPointer gamma- probe and 99mTc-labeled radiopharmaceutical preparation kits for high-tech patient care.

The RadPointer Intraoperative Gamma-Probe is designed to search for and localize sentinel lymph nodes during diagnostic and surgical procedures.

 

Sentiscan®, 99mTc is a kit for the preparation of a radiopharmaceutical labeled with 99mTc, which is a nanocolloidal aluminum solution.

It is used for scintigraphic imaging and intraoperative detection of sentinel lymph nodes in patients with various malignant neoplasms (including breast, melanoma of the skin, larynx and laryngopharynx, oral mucosa, vulva, cervix, endometrium, etc.).

Also, the line of kits for the preparation of diagnostic radiopharmaceuticals produced by MedicorPharma-Ural LLC includes drugs for the diagnosis of malignant tumors of the prostate, brain and neuroendocrine tumors.

 

MedicorPharma-Ural LLC has all the necessary licenses, including a license to operate radiation sources and to carry out pharmaceutical activities. It is also certified according to international operating standards ISO 9001:2015 (GOST R ISO 9001-2015 Quality management systems. Requirements), ISO 13485:2017 (GOST ISO 13485-2017 Medical devices. Quality management systems. Requirements for regulatory purposes).

28/1, Kirova St., Ekaterinburg

+7 (343) 270-75-29

8 800 600 33 90

info@mphu.ru

www.mphu.ru